Search Results - "Walentynowicz, Kacper A"

Single-cell heterogeneity of EGFR and CDK4 co-amplification is linked to immune infiltration in glioblastoma by Walentynowicz, Kacper A., Engelhardt, Dalit, Cristea, Simona, Yadav, Shreya, Onubogu, Ugoma, Salatino, Roberto, Maerken, Melanie, Vincentelli, Cristina, Jhaveri, Aashna, Geisberg, Jacob, McDonald, Thomas O., Michor, Franziska, Janiszewska, Michalina

“…Glioblastoma (GBM) is the most aggressive brain tumor, with a median survival of ∼15 months. Targeted approaches have not been successful in this tumor type…”
Get full text

In Search for Reliable Markers of Glioma-Induced Polarization of Microglia by Walentynowicz, Kacper A, Ochocka, Natalia, Pasierbinska, Maria, Wojnicki, Kamil, Stepniak, Karolina, Mieczkowski, Jakub, Ciechomska, Iwona A, Kaminska, Bozena

“…Immune cells accumulating in the microenvironment of malignant tumors are tumor educated and contribute to its growth, progression, and evasion of antitumor…”
Get full text

Immune microenvironment of gliomas by Gieryng, Anna, Pszczolkowska, Dominika, Walentynowicz, Kacper A, Rajan, Wenson D, Kaminska, Bozena

“…High-grade gliomas are rapidly progressing tumors of the central nervous system (CNS) with a very poor prognosis despite extensive resection combined with…”
Get full text

Abstract IA10: Uncovering the ecology of glioblastoma with spatial digital profiling and single cell genotyping by Walentynowicz, Kacper A., Yadav, Shreya, Vincentelli, Cristina, Janiszewska, Michalina

“…Glioblastoma (GBM) remains one of the biggest challenges in oncology, with median survival of ~15 months. Extreme heterogeneity of the GBM cells within each…”
Get full text

Abstract IA013: Genetic heterogeneity and tumor microenvironment in glioblastoma by Walentynowicz, Kacper A., Engelhardt, Dalit, Yadav, Shreya, Onubogu, Ugoma, Salatino, Roberto, Vincentelli, Cristina, McDonald, Thomas O., Michor, Franziska, Janiszewska, Michalina

“…Glioblastoma (GBM), the most aggressive brain tumor, remains an unmet medical need. Despite aggressive chemotherapy, radiation and surgery, only 5.6% of…”
Get full text